Teladoc Health (TDOC) Cash from Financing Activities (2014 - 2026)

Teladoc Health has disclosed Cash from Financing Activities across 13 years of filings, most recently posting -$2.4 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$2.4 million, down 418.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$554.9 million (down 7669.85% YoY), and the FY2025 annual result was -$551.7 million, down 6736.81% from the prior year.
• Cash from Financing Activities came in at -$2.4 million for Q1 2026 at Teladoc Health, down from $1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $5.1 million in Q3 2023 to a low of -$549.9 million in Q2 2025.
• The 5-year median for Cash from Financing Activities is $1.1 million (2025), against an average of -$31.1 million.
• Across the five-year window, Cash from Financing Activities surged 699.37% in 2023 and slumped 14552.9% in 2025, its largest moves.
• Teladoc Health's Cash from Financing Activities stood at $4.4 million in 2022, then plunged by 140.52% to -$1.8 million in 2023, then soared by 215.94% to $2.1 million in 2024, then slumped by 46.36% to $1.1 million in 2025, then sank by 321.83% to -$2.4 million in 2026.
• The last three Cash from Financing Activities figures came in at -$2.4 million (Q1 2026), $1.1 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.